Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
Kang Wang, Yunlong Cao, Yunjiao Zhou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3–9-month intervals following two-dose inactivated vaccine (CoronaVac)
Yuting Liao, Ying-ping Chen, Bo Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition
Shuyuan Qiao, Shuyuan Zhang, Jiwan Ge, et al.
FEBS Open Bio (2022) Vol. 12, Iss. 9, pp. 1602-1622
Open Access | Times Cited: 9
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Zhenhao Fang, Lei Peng, Renata B. Filler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
Ritthideach Yorsaeng, Nungruthai Suntronwong, Harit Phowatthanasathian, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
Jorge A. Soto, Felipe Melo-González, Cristián Gutiérrez-Vera, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Immunogenicity and safety of a recombinant COVID-19 vaccine (ZF2001) as heterologous booster after priming with inactivated vaccine in healthy children and adolescents aged 3-17 years: an open-labeled, single-arm clinical trial
Tao Huang, Qianqian Hu, Zhou Xiang, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern
Bárbara M. Schultz, Felipe Melo-González, Luisa F. Duarte, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Sequential Administration of SARS-CoV-2 Strains-Based Vaccines Effectively Induces Potent Immune Responses against Previously Unexposed Omicron Strain
Qianying Wang, Shuhui Wang, Ying Liu, et al.
Pathogens (2023) Vol. 12, Iss. 5, pp. 655-655
Open Access | Times Cited: 2
Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
Ying Chen, Caiqin Hu, Zheng Wang, et al.
(2023)
Open Access | Times Cited: 2
Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
Ying Chen, Caiqin Hu, Zheng Wang, et al.
Pathogens (2023) Vol. 12, Iss. 10, pp. 1254-1254
Open Access | Times Cited: 2
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
Yihao Liu, Qin Zeng, Caiguanxi Deng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
Jianhua Li, Xiaoyan Li, Erqiang Wang, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2111-2111
Open Access | Times Cited: 3
Evaluation of the Efficacy of Chinese Inactivated COVID-19 Vaccines against the Delta Variant in the Nanjing Outbreak: A Cohort Study
Fuqun Liu, Shufei Wu, Mengying Liu, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 10016-10016
Closed Access
A subset of Memory B-derived antibody repertoire from 3-dose vaccinees is ultrapotent against diverse and highly transmissible SARS-CoV-2 variants, including Omicron
Kang Wang, Zijing Jia, Linlin Bao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Development of a rapid neutralizing antibody test for SARS-CoV-2 and its application for neutralizing antibody screening and vaccinated serum testing
Yuchang Li, Mingyue Wang, Hongzhen Wu, et al.
Infectious Medicine (2022) Vol. 1, Iss. 2, pp. 95-102
Open Access | Times Cited: 2
A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD
Shuo Liu, Zijing Jia, Jianhui Nie, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Observational study of antibody levels after second and third SARS‐CoV‐2 vaccinations in medical workers
Qing Liu, Wenyan Zhou, Wencan Jiang, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 1
Immunogenicity of inactivated coronavirus disease 2019 vaccines in patients with chronic hepatitis B undergoing antiviral therapy
Wenxin Wang, Jia Rui, Jin‐Wen Song, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 1
Vaccines against COVID-19 available in Brazil
Grega Rúbia Bee, Daniel Damazio Pinto, Ana Claudia Costa Alves da Silva, et al.
Seven Editora eBooks (2023)
Open Access
Immunogenicity Persistence of a Third-Dose Homologous BBIBP-CorV/CoronaVac Boosting Vaccination: A Prospective Open-Label Study
Na Ren, Zhihong Wang, Sikang Gao
Viral Immunology (2023) Vol. 37, Iss. 1, pp. 16-23
Closed Access
Immunogenicity of BNT162b2 and CoronaVac boosters in fully vaccinated individuals with CoronaVac against SARS-CoV-2: A Longitudinal Study
Füsun Can, Zeynep Ece Kuloğlu, Rojbin El, et al.
Authorea (Authorea) (2022)
Open Access
Previous Page - Page 2

Scroll to top